SonaCare Medical Board of Directors to Include Members with Extensive Health Care and Executive Business Management Experience

CHARLOTTE, NC -- SonaCare Medical, a leading manufacturer of medical High Intensity Focused Ultrasound (HIFU) devices, announced today that five new members have been selected to serve on the company's Board of Directors. The new members bring additional health care industry experience to the Board and include a physician and hospital CEO, a president of multiple medical companies, two founders of investment firms, and SonaCare Medical's newly appointed CEO. The new Board members are Evan Bakst, Dr. Mark Carol, David Koslosky, Dr. Bruce Murphy, and Dr. John Wilkerson. They join the Chairman of the Board, Thomas Mendell, along with Co-Founder and Board Member, Stephen Puckett, Sr.

Read more: SonaCare Medical Announces New Members To The Board of Directors

Sonatherm^® Laparoscopic HIFU device used to demonstrate thermal ablation at hands-on lab

CHARLOTTE, NC -- SonaCare Medical, a leading manufacturer of medical High Intensity Focused Ultrasound (HIFU) devices, recently participated in the American Urology Association's (AUA) surgical summit "Small Renal Mass 360°." Key opinion leaders in urology presented on the latest diagnostic and therapeutic advances related to small renal masses while attendees had the opportunity to evaluate and learn about different ablative technologies in hands-on labs. Attendees at the Los Angeles, CA lab, under direction of course director Inderbir Gill, MD, successfully used the Sonatherm^® (HIFU) device to laparoscopically ablate porcine kidney tissue as well as the bladder wall. Dr. Gill had previously performed the first outpatient renal ablation with Sonatherm^®.

Read more: SonaCare Medical Supports American Urology Association's Small Renal Mass 360° Summit

Dr. David Schulsinger spearheads pilot study for ablation of renal cell carcinoma with SonaCare Medical's Sonatherm^®Laparoscopic Soft Tissue HIFU Surgical Ablation Device

Charlotte, NC. October 28, 2014 -- SonaCare Medical, manufacturer of High Intensity Focused Ultrasound (HIFU) ablative devices, announces ongoing progress at Stony Brook University in Stony Brook, NY where Dr. David Schulsinger and his team are conducting the first North American Institutional Review Board (IRB) approved treat and resect study of kidney cancer in humans with SonaCare's Sonatherm^® laparoscopic soft tissue HIFU Surgical Ablation Device.

Read more: Leading Researcher at Stony Brook University Pioneering Groundbreaking Sound Based Technology to...

"Beyond being a true visionary, Mark has the experience to lead SonaCare both strategically and on a day-to-day basis."

CHARLOTTE, NC. -- SonaCare Medical, LLC, leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced that its Board of Directors has appointed Dr. Mark Carol, M.D. as Chief Executive Officer, President and member of the Board effective immediately. In his new role Dr. Carol will take-on expanded responsibilities within the company, including further developing the company's HIFU technology, as well as overseeing commercialization, manufacturing and finance. 

Read more: Board of Directors Appoints Dr. Mark Carol as CEO and President

FRIDAY, OCTOBER 3, 2014 CHARLOTTE, NC.  SonaCare Medical, LLC, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced that the Gastroenterology and Urology Device Panel met on Wednesday October 1st with representatives from the FDA and SonaCare Medical to review and vote on recommendations for the interim analysis of SonaCare Medical's Sonablate^® 450's safety, efficacy, and risk/benefits ratio for the treatment of biopsy proven recurrent prostate cancer, stage T1c-T2, in patients who have failed primary external beam radiation therapy and have a PSA≤10 ng/mL.

Read more: SonaCare Medical FDA Panel Review for Its Sonablate® 450 Prostate Ablation System